Product Information
MEMANTINE HCL 5 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0793 per EA under NDC 68180022907. Its NADAC has been published 572 times since Oct 21, 2015.
FDA first approved this application on Apr 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180022907
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090051FDA Approved
4/10/2015
TE Code
AB
On Market Since
7/13/2015
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 5 MG TABLET has been published 572 times since Oct 21, 2015, and over the history we have for it it has declined 75.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0793 per EA |
|---|---|
| All-time high | $0.3786 (Jan 13, 2016) |
| All-time low | $0.0674 (Nov 20, 2024) |
| 52-week high | $0.0838 |
| 52-week low | $0.0788 |
| Median price | $0.0962 |
| Average price | $0.1297 |
| Largest weekly change | +22.2% (Aug 21, 2024) |
| Weeks tracked | 572 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Memantine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Memantine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 5 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0793 per EA (NDC 68180022907), effective Sep 30, 2026.
How has the price of MEMANTINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 5 MG TABLET has declined 75.0%. It has been tracked across 572 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 5 MG TABLET?
Since Oct 21, 2015, the NADAC for MEMANTINE HCL 5 MG TABLET has ranged from a low of $0.0674 (Nov 20, 2024) to a high of $0.3786 (Jan 13, 2016), with a median of $0.0962 per EA.
Are there cheaper alternatives to MEMANTINE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MEMANTINE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEMANTINE HCL 5 MG TABLET?
MEMANTINE HCL 5 MG TABLET (NDC 68180022907) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.